Cerecor Inc. CERC
Trading inactive
| Name of reporting person | Citizenship or organization | Sole voting power | Shared voting power | Sole dispositive power | Shared dispositive power | Amount beneficially owned | Percent of class | Accepted date |
|---|---|---|---|---|---|---|---|---|
| OrbiMed Advisors LLC | Delaware | 0 | 967000 | 0 | 0 | 967000 | 9.9 % | 14/11/2024 |
| OrbiMed Capital GP IX LLC | Delaware | 0 | 644667 | 0 | 0 | 644667 | 6.7 % | 14/11/2024 |
| Neil Shahrestani | Delaware | 0 | 970359 | 0 | 0 | 970359 | 10.02 % | 07/10/2024 |
| Ikarian Capital, LLC | Delaware | 0 | 970359 | 0 | 970359 | 970359 | 10.02 % | 07/10/2024 |
| BVF Partners L.P. | Delaware | 0 | 0 | 0 | 967299 | 967299 | 9.99 % | 23/08/2024 |
| BVF I GP LLC | Delaware | 0 | 0 | 0 | 512349 | 512349 | 5.3 % | 23/08/2024 |
| Biotechnology Value Fund II, L.P. | Delaware | 0 | 0 | 0 | 403121 | 403121 | 4.2 % | 23/08/2024 |
| BVF GP Holdings LLC | Delaware | 0 | 0 | 0 | 915470 | 915470 | 9.5 % | 23/08/2024 |
| BVF Inc. | Delaware | 0 | 0 | 0 | 967299 | 967299 | 9.99 % | 23/08/2024 |
| Mark N. Lampert | Delaware | 0 | 0 | 0 | 967299 | 967299 | 9.99 % | 23/08/2024 |
| BVF II GP LLC | Delaware | 0 | 0 | 0 | 403121 | 403121 | 4.2 % | 23/08/2024 |
| Biotechnology Value Trading Fund OS LP | Delaware | 0 | 0 | 0 | 37791 | 37791 | 1 % | 23/08/2024 |
| BVF Partners OS Ltd. | Delaware | 0 | 0 | 0 | 37791 | 37791 | 1 % | 23/08/2024 |
| Biotechnology Value Fund, L.P. | Delaware | 0 | 0 | 0 | 512349 | 512349 | 5.3 % | 23/08/2024 |
| s | Delaware | 0 | 967299 | 0 | 0 | 967299 | 9.99 % | 23/08/2024 |
| s | Delaware | 0 | 967299 | 0 | 0 | 967299 | 9.99 % | 23/08/2024 |
| s | Delaware | 0 | 967299 | 0 | 0 | 967299 | 9.99 % | 23/08/2024 |
| s | Delaware | 0 | 967299 | 0 | 0 | 967299 | 9.99 % | 23/08/2024 |
| J. Crutcher | USA | 110851 | 0 | 110851 | 0 | 110851 | 9.9 % | 23/08/2024 |